Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Andringa

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Neural Transmission. Supplementum|February 24, 2001
The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkeyG Andringa, A R Cools
Psychopharmacology|December 14, 1999
Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesiaG Andringa, J C Stoof, A R Cools
Neuroscience Letters|February 17, 2007
The thiol antioxidant 1,2-dithiole-3-thione stimulates the expression of heat shock protein 70 in dopaminergic PC12 cellsG Andringa, C A M Jongenelen, L Halfhide, et al.
Neuropharmacology|January 24, 2002
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?A R Cools, L Lubbers, R V van Oosten, et al.
Behavioural Pharmacology|April 26, 2000
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958G Andringa, L Lubbers, B Drukarch, et al.
Aging & Mental Health|September 29, 2025
A scoping review of influencing factors associated with loneliness in nursing home settingsD van de Kolk, G Andringa, D F de Korne, et al.
European Journal of Pharmacology|January 27, 1999
The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptorsG Andringa, B Drukarch, J E Leysen, et al.
Neurochemistry International|January 30, 2013
Motor behavior correlates with striatal [¹⁸F]-DOPA uptake in MPTP-lesioned primatesR Kortekaas, S A Eshuis, G Andringa, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2005
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytesB Drukarch, J Flier, C A M Jongenelen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 6, 2004
Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's diseaseG Andringa, K Y Lam, M Chegary, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Neural Transmission. Supplementum|February 24, 2001
The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkeyG Andringa, A R Cools
Psychopharmacology|December 14, 1999
Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesiaG Andringa, J C Stoof, A R Cools
Neuroscience Letters|February 17, 2007
The thiol antioxidant 1,2-dithiole-3-thione stimulates the expression of heat shock protein 70 in dopaminergic PC12 cellsG Andringa, C A M Jongenelen, L Halfhide, et al.
Neuropharmacology|January 24, 2002
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?A R Cools, L Lubbers, R V van Oosten, et al.
Behavioural Pharmacology|April 26, 2000
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958G Andringa, L Lubbers, B Drukarch, et al.
Aging & Mental Health|September 29, 2025
A scoping review of influencing factors associated with loneliness in nursing home settingsD van de Kolk, G Andringa, D F de Korne, et al.
European Journal of Pharmacology|January 27, 1999
The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptorsG Andringa, B Drukarch, J E Leysen, et al.
Neurochemistry International|January 30, 2013
Motor behavior correlates with striatal [¹⁸F]-DOPA uptake in MPTP-lesioned primatesR Kortekaas, S A Eshuis, G Andringa, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2005
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytesB Drukarch, J Flier, C A M Jongenelen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 6, 2004
Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's diseaseG Andringa, K Y Lam, M Chegary, et al.
Pageof 2